When Is a Director Not a Director?
Nick Porter, legal director at Buckles law firm, discusses the governance risk hiding inside many aesthetic clinics
Titles carry weight in aesthetic medicine. They reassure patients, signal professionalism and help define the culture of a clinic. But behind the polished reception desks, immaculate treatment rooms and tightly managed diaries, many aesthetic businesses operate with informal structures that bear little resemblance to their legal framework. Clinic managers step into strategic roles, practitioners approve spending, founders influence decisions long after stepping back from day-to-day involvement, and long-standing staff members become the unofficial voice of authority simply because they are trusted.
This flexibility suits a sector built on relationships and rapid commercial evolution, yet it creates a governance risk that is often invisible until something goes wrong. Under UK company law, an individual can become a director not because of the title printed beneath their name, but because of what they do. If a person behaves like a director, influences the direction of the business or is treated as one by colleagues and commercial partners, they may be regarded as a director in law, even if they have never been formally appointed.
For aesthetic clinics, where business decisions interact closely with patient safety, clinical governance and reputational stakes, this distinction matters more than many realise.
How an individual becomes a director without ever being appointed
Two legal concepts describe individuals who occupy director-level responsibility unintentionally. The first is the de facto director: someone who carries out tasks normally expected of a member of the board. In the aesthetics sector, this might include shaping the treatment portfolio, directing marketing strategy, setting prices, choosing suppliers, approving the purchase of high-value devices, leading recruitment, or determining how the clinic responds to competitive pressures. A practice manager who effectively oversees commercial direction, or a practitioner who leads all non-clinical decisions, may fall within this category.
The second is the shadow director: someone whose instructions the official directors generally follow. In aesthetics, it is common for investors, spouses, silent partners or medically qualified practitioners to exert considerable influence behind the scenes. A business may be shaped as much by their preferences as by those of the named directors. When this happens, the law may treat that influence as a form of directorship.
In both scenarios, the central factor is conduct. The law examines what the person actually does, not what appears in Companies House filings or on the clinic’s website. If an individual regularly influences direction, expenditure, staffing or strategy, they may be treated as a director, even if no one within the clinic considers them one.
Why this creates particular risks in aesthetic medicine
Aesthetic medicine is unlike most consumer-facing sectors. Decisions about treatments, marketing and operations sit alongside regulatory requirements, clinical standards, duty-of-care obligations and professional ethics. A person who is, in practice, directing the clinic may find themselves responsible for far more than the commercial performance of the business. They may be held accountable for compliance failures, clinical governance issues or operational problems that they never expected to fall within their remit.
Once someone is treated as a director in law, they are bound by statutory directors’ duties. These duties include acting in the best interests of the company, exercising reasonable care and skill and avoiding any personal conflict between their own interests and those of the business. These obligations apply automatically. They do not depend on whether the individual realises they are acting as a director, nor on whether the business intended them to.
When things are going well, these duties may feel irrelevant. They become painfully visible only when the clinic faces stress: a shareholder disagreement, an insurance dispute, unresolved patient complaints, a regulatory investigation, a difficult investor relationship or the financial strain that arises when bookings decline or fixed costs increase. Decisions made informally and with good intentions may later be interpreted as failed governance, especially if the individual was, in reality, functioning as a director.
What can happen when things go wrong
A person who breaches directors’ duties can be required to compensate the company financially, to repay any benefit they received, or to face legal action brought by shareholders or insolvency practitioners. Their name may appear in judgments or regulatory reports that can be accessed by insurers, lenders, partners and potential employers. In a sector where reputation is central to patient trust and commercial viability, the damage can be long-lasting.
The risk becomes severe if the business experiences financial distress. Insolvency practitioners are required to scrutinise who controlled decisions in the period leading up to failure. If a clinic continued trading while insolvency was inevitable, those involved in directing the business may be accused of wrongful trading. The court can order them to contribute personally to the company’s debts. In cases involving dishonesty, fraudulent trading may be alleged, bringing both civil and potentially criminal consequences.
These risks are particularly pertinent in aesthetic medicine, where deposits, treatment packages and prepayments are common. Continuing to take bookings or accept payments when the business lacks the resources to deliver services can be viewed unfavourably. Those effectively running the clinic may find themselves personally accountable, even if their official job title suggests a purely operational role.
Why titles cause unexpected problems
The aesthetics industry uses director-level titles widely. “Clinic Director”, “Medical Director”, “Aesthetic Director”, “Brand Director” and similar labels appear across websites, brochures, consent forms, uniforms and social media profiles. While these titles project professionalism, they can inadvertently signal to regulators, courts and commercial partners that the individual holds formal legal authority.
If the person with such a title also participates in decisions about staffing, finances, marketing or treatment offerings, the combination can lead a court to conclude that they were acting as a director. In multi-site businesses, franchise networks and clinical partnerships, this risk multiplies. A person may carry the same title as an actual director in another branch, creating ambiguity that is difficult to justify in a dispute.
How aesthetic clinics can protect themselves
The most effective protection comes from aligning language with reality. Titles should accurately reflect the responsibilities of the role. If someone genuinely performs director-level tasks, a formal appointment is the safer and more transparent option. If not, titles that imply board-level authority should be avoided.
Clear governance structures are equally important. Clinics should periodically review who makes key decisions, who signs off on expenditure, who leads strategy, who represents the business externally and who influences the work of others. Many businesses discover that authority has shifted informally over time, particularly as clinics expand, diversify or introduce advanced treatments requiring significant investment.
Training, communication and awareness are essential. Senior staff often do not realise the legal significance of the responsibilities they have assumed. Ensuring they understand where their authority begins and ends helps protect both the individual and the organisation.
A final reflection
Aesthetic medicine depends on trust – from patients, insurers, regulators and the wider public. That trust is grounded not only in clinical skill, but also in the professionalism with which clinics are run. Titles are easy to assign. Real authority is harder to define. The law cares only about the latter.
In a sector where commercial decisions intersect so closely with patient safety and regulatory scrutiny, understanding who truly directs the business is essential. Many clinics already have more directors than they realise.
